News

The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.

Three of the twelve positions at the forefront of research into myeloid diseases will be based at the Josep Carreras Leukaemia Research Institute as part of the Innovative Training Network (ITN) entitled INTERCEPT-MDS. The Josep Carreras Institute coordinates this Marie Skłodowska Curie Action funded by the European Commission under the H2020 framework.

The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.
The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.

A call to recruit twelve PhD candidates for an innovative European network coordinated by the Josep Carreras Institute opens on 11 January 2021 with an application deadline of 23 February 2021.

The three new PhD candidates to be based at the Josep Carreras Institute headquarters will have nine counterparts at other leading European research institutions. The start date of the fellowships will be between July and October 2021.

Two of the three positions offered by the Josep Carreras Institute will be supervised by Dr. Marcus Buschbeck, group leader and coordinator of the INTERCEPT-MDS project. The third position will be supervised by Dr. Maria Berdasco and Prof. Manel Esteller.

The positions are targeted at applicants with no more than four years’ research experience and offer an incomparable opportunity to receive an outstanding and tailored training in the innovative emerging field of disease interception. In addition to the training offered by the supervisors, universities, and other institutions participating in the network, the PhD candidates will also carry out research stays at other European institutions within the INTERCEPT-MDS project.

Disease interception is a novel concept referring to the treatment of a disease before it fully develops, by removing altered cells. There are many challenges that researchers need to overcome to make disease interception a reality, and the complementary projects that the twelve PhD candidates will work on will address these challenges with single cell genomics tools and by exploring its epigenetics, to advance the field substantially during the years of the fellowships.

The INTERCEPT-MDS application portal, with the application guidelines, full details of the PhD fellowships, projects and eligibility requirements can be found here.

Please use the social media buttons above to share this opportunity with your network and help us find the perfect candidates to advance our knowledge in the exciting field of disease interception!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 953407

If you have any questions please contact us on: intercept-mds@carrerasresearch.org



Back